CN107530423A
|
|
With anti-LAP mab treatments cancer
|
WO2016081792A1
|
|
System and method for wave interference analysis and titration
|
WO2016081419A2
|
|
Mitochondrial phosphate carrier targets for treating soft-tissue calcification
|
WO2016064895A1
|
|
Targeting apolipoprotein e (apoe) in neurologic disease
|
WO2016057700A1
|
|
Oxylipin-peptide conjugated mediators that promote resolution of infection, organ protection and tissue regeneration
|
WO2016033187A1
|
|
Use of gelsolin in the treatment and diagnosis of sickle cell disease
|
WO2016019371A1
|
|
Volatile organic compounds (vocs) for the diagnosis of clostridium difficile-associated diarrhea (cdad)
|
WO2016011137A1
|
|
Systems and methods for generating biomarkers based on multivariate classification of functional imaging and associated data
|
WO2015200576A1
|
|
Systems and methods for controlling focused ultrasound to target release of a therapeutic agent from temperature-sensitive liposomal carriers
|
WO2015179858A1
|
|
Detectors, system and method for detecting ionizing radiation using high energy current
|
US2016015592A1
|
|
Micromechanical Force Devices for Wound Healing Acceleration
|
WO2015171641A1
|
|
Coordinate control of pathogenic signaling by the mir-130/301 family in pulmonary hypertension and fibroproliferative diseases
|
WO2015164586A1
|
|
Targeting parp1 for treatment of tsc and cancers
|
WO2015164364A2
|
|
Methods to manipulate alpha-fetoprotein (afp)
|
WO2015160805A1
|
|
Circulating kim-1 levels for detection of pathologies associated with injury to, or cancer of, the kidney
|
WO2015160786A1
|
|
Method of diagnosing, prognosing, and treating lupus nephritis
|
WO2015153614A1
|
|
System and method for quantitative imaging using multiple magnetization pathways
|
WO2015149001A1
|
|
Metabolically-activated drug conjugates to overcome resistance in cancer therapy
|
WO2015148654A1
|
|
Compositions and methods for inhibiting bmp
|
WO2015095790A1
|
|
Ductile crosslinked polymers and methods of making the same
|